Washington BioLeaders Forum
Phacilitate Washington celebrated its 10th Anniversary in great style, with a record attendance and high overall approval rating for the event which took place in January.
The Cell & Gene Therapy Forum cemented its status as the world’s premier event for the sector’s senior decision-makers. The addition of the Immunotherapy Forum – focused exclusively on active immunotherapeutic technologies – proved to be a great success given the substantial crossover between the two. Indeed, the two sessions which were shared between C> and Immunotherapy programmes – covering CARs and cancer vaccines respectively– were among the best received of the meeting.
The 13th Annual Phacilitate Vaccine Forum continued to drive the agenda for industry, Government and NGO leaders from the prophylactic vaccine field. Last, but not least, The Stem Cells as Discovery Research Tools event also enjoyed a successful launch, representing another welcome foray into a complementary technology area.
The event featured a number of other ‘firsts’ and records for Phacilitate:
- The launch of the annual Bioleaders Power 10 award at our Gala Dinner (attended by around 200 attendees). The inaugural award was presented to Dr Anthony Fauci, Director of NIAID, NIH. His award was accepted on his behalf by Dr Carole Heilman, Director of DMID.
- Overall, Phacilitate Washington attracted well over 500 attendees to Washington, DC.
- 60 sponsors and exhibitors supported the event
Washington BioLeaders Forum 2015 - 26-28 January 2015, Grand Hyatt, Washington DC. - Save the Date!
What’s happening in 2015?
- Expanded Cell & Gene Therapy Forum and Immunotherapy Forum agendas, including dedicated 3-days streams focusing on manufacture, R&D/clinical development, logistics, regulatory affairs and more
- New app-based pre-event online networking service
- Largest ever speaker panel – expect well over 150 bioleaders
- Annual Gala Awards Dinner
- Redesigned and expanded exhibition area
- Novel formats that we are looking to build into the conference agenda include:
- Interactive ‘Meet the Professor’ sessions – academic opinion leaders in open Q&A
- Working Lunch discussions for small groups
- ‘Tech room’ demonstrations
- White paper/clinical review data sessions
- 1-on-1 regulatory ‘drop in clinics’
- Speed networking sessions
- ‘Behind Closed Doors’ Advisory Board-led summit meetings
Have your say on these ideas, or confirm your involvement – contact Phacilitate today!